Mastercard and Gilead Partner to Simplify Delivery of Hepatitis Treatment in Pakistan

Oct 1, 2018 6:00 PM ET

Last year, in partnership with Mastercard and the World Hepatitis Alliance, we launched a pilot program in Pakistan to simplify the delivery of HCV treatment in a resource-limited setting with high disease burden.

Learn more in the video above.

Mastercard and Gilead Partner to Simplify Delivery of Hepatitis Treatment in Pakistan

More from Gilead Sciences

Gilead Sciences Champions Equal Pay

Winn Awards Help Physicians Solve Healthcare Disparities

Gilead Helps Launch Türkiye’s First HIV Testing Week

Gilead Science Supports Increasing Diversity in Clinical Trials: 2024 Toward Health Equity Oncology Grant Supports 36 Global Organizations

Gilead Sciences Aids in Reducing Cancer Care Disparities: Dale Shares Her Breast Cancer Journey and the Power of Information Sharing

Gilead Sciences CEO on Company’s Evolution and Commitment to the Bay Area

Gilead Sciences: National Black HIV/AIDS Awareness Day

Gilead Announces Funding Initiative To Support HIV Prevention, Anti-Stigma and Health Equity Efforts for Black Cisgender and Transgender Women and Girls in the U.S.